Sheila A. Peters
Astrazeneca R&D
Moelndal, O, Sweden
Moelndal, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
The quest to define cancer-specific systems parameters for personalized dosing in oncology.
Journal: Expert opinion on drug metabolism & toxicology
Published: March 05, 2025
Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs.
Journal: Clinical pharmacokinetics
Published: December 31, 2024
Solubility-Limited Absorption Identified by a Simplified PBPK Model for the Prediction of Positive Food Effect for BCS II/IV Drugs.
Journal: Clinical pharmacokinetics
Published: December 31, 2024
Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.
Journal: CPT: pharmacometrics & systems pharmacology
Published: December 19, 2024
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global Convergence.
Journal: Clinical pharmacology and therapeutics
Published: November 28, 2024
Can Mechanistic Static Models for Drug-Drug Interactions Support Regulatory Filing for Study Waivers and Label Recommendations?
Journal: Clinical pharmacokinetics
Published: December 12, 2022
Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis.
Journal: Frontiers in oncology
Published: August 03, 2022
Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects.
Journal: British journal of clinical pharmacology
Published: July 22, 2021
Hepatic Scaling Factors for In Vitro-In Vivo Extrapolation of Metabolic Drug Clearance in Patients with Colorectal Cancer with Liver Metastasis.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: January 05, 2021
Physiologically-Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective.
Journal: Clinical pharmacology and therapeutics
Published: June 23, 2020
Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: March 22, 2020
Prediction of active human dose: learnings from 20 years of Merck KGaA experience, illustrated by case studies.
Journal: Drug discovery today
Published: September 29, 2019
Last Updated: 09/26/2026